The Metabolic Vulnerability Index (MVX) is a revolutionary new algorithmic test that quantifies six key biomarkers — small HDL particles, GlycA, branched-chain amino acids (valine, leucine, isoleucine) and citrate—each highly predictive of poor cardiometabolic outcomes.

Combined into a single Index score from 1 to 100, the MVX identifies drivers of poor health often years before symptoms appear. The MVX Plus provides insight into toxin exposures, latent infections, systemic inflammation, and mitochondrial dysfunction. Also available are sub-indexes for Inflammation Vulnerability and Metabolic Malnutrition.

Innovative, inexpensive, and now widely accessible, the MVX empowers you to measure, guide, and track your patients’ health with scientific precision.

Join Dr. Darren Schmidt—the nation’s foremost experts on the clinical application of MVX—for an in-depth look at what this test detects, how to implement it in real-world practice, and most importantly, how it can strengthen your clinical acumen and improve your patients’ lives!

SPONSORED BY: Professional Co-op Services